[Federal Register Volume 63, Number 28 (Wednesday, February 11, 1998)]
[Notices]
[Page 7054]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-3491]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Recombinant DNA Advisory Committee; Notice of Meeting

    Pursuant to Public Law 92-463, notice is hereby given of a meeting 
of the Recombinant DNA Advisory Committee on March 10, 1998. The 
meeting will be held at the National Institutes of Health, Building 
31C, 6th Floor, Conference Room 10, 9000 Rockville Pike, Bethesda, 
Maryland 20892, starting on March 10, 1998, at approximately 9 a.m., 
and will recess at approximately 5 p.m. The meeting will be open to the 
public to discuss Proposed Actions under the NIH Guidelines for 
Research Involving Recombinant DNA Molecules (59 FR 34496) and other 
matters to be considered by the Committee. The Proposed Actions to be 
discussed will follow this notice of meeting. Attendance by the public 
will be limited to space available.
    Debra W. Knorr, Acting Director, Office of Recombinant DNA 
Activities, National Institutes of Health, MSC 7010, 6000 Executive 
Boulevard, Suite 302, Bethesda, Maryland 20892-7010, Phone (301) 496-
9838, FAX (301) 496-9839, will provide summaries of the meeting and a 
roster of committee members upon request. Individuals who plan to 
attend and need special assistance, such as sign language 
interpretation or other reasonable accommodations, should contact Ms. 
Knorr in advance of the meeting.
    OMB's ``Mandatory Information Requirements for Federal Assistance 
Program Announcements'' (45 FR 39592, June 11, 1980) requires a 
statement concerning the official government programs contained in the 
Catalog of Federal Domestic Assistance. Normally NIH lists in its 
announcements the number and title of affected individual programs for 
the guidance of the public. Because the guidance in this notice covers 
virtually every NIH and Federal research program in which DNA 
recombinant molecule techniques could be used, it has been determined 
not to be cost effective or in the public interest to attempt to list 
these programs. Such a list would likely require several additional 
pages. In addition, NIH could not be certain that every Federal program 
would be included as many Federal agencies, as well as private 
organizations, both national and international, have elected to follow 
the NIH Guidelines. In lieu of the individual program listing, NIH 
invites readers to direct questions to the information address above 
about whether individual programs listed in the Catalog of Federal 
Domestic Assistance are affected.

    Dated: February 2, 1998.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 98-3491 Filed 2-10-98; 8:45 am]
BILLING CODE 4140-01-P